Translate Bio Competitors, Revenue and Alternatives

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:N/A
Industry:Biotech
Founded:2011
Lead Investor(s):N/A
Press
Claim your profile

City Ranking

Industry Ranking

State Ranking

Estimated Revenue & Financials

  • Translate Bio's estimated annual revenue is currently $0.2M per year.
  • Translate Bio's estimated revenue per employee is $2,070

Employee Data

  • Translate Bio has 115 Employees.
  • Translate Bio grew their employee count by 32% last year.
  • Translate Bio currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$7.1M5660%N/A
Tango Therapeut...
$9M8338%N/A
Compass Therape...
$15.8M10614%N/A
Cell Signaling ...
$75.6M577N/AN/A
Momenta Pharmac...
N/A220N/AN/A
Emulate
$14.7M99-17%N/A
ArQule
N/A94N/AN/A
Hamilton Storag...
$14.6M1119%N/A
Alnylam Pharmac...
$74.9M127731%N/A
Transgenomic
N/A47N/AN/A
Missing a competitor? Contribute!?
Submit

Translate Bio is a leading biotechnology company focused on pioneering the translation of RNA science into therapeutics promoting healthy gene expression in people living with debilitating genetic diseases. The company's RNA platforms for powering endogenous therapeutic protein production is applicable to a broad range of diseases caused by insufficient protein production, including rare diseases of the liver, lung and central nervous system (CNS).

keywords:N/A

115

Number of Employees

$0.2M

Revenue (est)

1

Current Jobs

32%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Executive Contacts

NameTitleEmail
Richard WoosterChief Scientific OfficerEmail Available
Paul BurgessGeneral Counsel
Michelle GrossmanClinical Trial ManagerEmail Available
Will CaronManager of FP&AEmail Available
Christian CobaughSenior Director, Research Discovery & Process Development
Caroline O'HaraDirector Clinical Operations
Gang SunDirector and Head, DMPK
Florence ChanDirector, Human Resources
Robert MeyerDirector (corparate board member)
Ann BarbierChief Medical Officer

Translate Bio News

12-Sep-19 - Translate Bio Announces Strategic Manufacturing Agreement ...

“At Translate Bio, we recognize the importance of developing scalable manufacturing processes in this innovative field and have made this a ...

10-Sep-19 - Translate Bio Drops Liver- Disease Program. The Stock Is ...

Translate Bio , a clinical-stage biotech company developing therapies based on synthetic mRNA, said Monday night that it was dropping one of ...

9-Sep-19 - Translate Bio bails on OTC deficiency candidate MRT5201

In a pipeline update, Translate Bio (NASDAQ:TBIO) announces that it will prioritize its pulmonary disease programs, including cystic fibrosis ...

Translate Bio Executive Hires

DateNameTitleReference
2017-11-07Ann BarbierChief Medical OfficerArticle
2018-05-24John SchroerChief Financial OfficerArticle